دورية أكاديمية

Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer

التفاصيل البيبلوغرافية
العنوان: Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer
المؤلفون: Simons, Martijn J. H. G., Retèl, Valesca P., Ramaekers, Bram L. T., Butter, Rogier, Mankor, Joanne M., Paats, Marthe S., Aerts, Joachim G. J. V., Mfumbilwa, Zakile A., Roepman, Paul, Coupé, Veerle M. H., Uyl-de Groot, Carin A., van Harten, Wim H., Joore, Manuela A.
المساهمون: ZonMw, KWF Kankerbestrijding, Achmea
المصدر: PharmacoEconomics ; volume 39, issue 12, page 1429-1442 ; ISSN 1170-7690 1179-2027
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2021
مصطلحات موضوعية: Public Health, Environmental and Occupational Health, Health Policy, Pharmacology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1007/s40273-021-01073-y
DOI: 10.1007/s40273-021-01073-y.pdf
DOI: 10.1007/s40273-021-01073-y/fulltext.html
الإتاحة: https://doi.org/10.1007/s40273-021-01073-yTest
حقوق: https://creativecommons.org/licenses/by-nc/4.0Test ; https://creativecommons.org/licenses/by-nc/4.0Test
رقم الانضمام: edsbas.2D12DA67
قاعدة البيانات: BASE